OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets
OneSource Speciality Pharma has entered into a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilar medicines for global markets, reinforcing India's growing role as...
Trump Announces Import Taxes on Generic Drugs to Boost US Manufacturing
US President Donald Trump has announced a new phased tariff policy targeting imported generic medicines, designed tostimulate biopharmaceutical companies to establish domestic manufacturing operations within the United...
Medtronic MEIC Expands Breast and Cervical Cancer Screenings in Hyderabad
The Medtronic Engineering and Innovation Center (MEIC) in Hyderabad has initiated a series of health and development initiatives aimed at uplifting underserved local communities.
Driven by Medtronic’s core mission...
Lupin Introduces Kaveri Therapeutics to Accelerate Cancer Drug Development
Lupin Limited announced the strategic spin-out of two promising oncology assets LNP7457 (PRMT5) and LNP8701 (SOS1) into Kaveri Therapeutics Inc. , a U.S.-based, clinical-stage oncology company dedicated to advancing targeted...
CBN India Seizes Illicit Trafficking of 12 Crore Tramadol Tablets under “Operation Vajra”
The Central Bureau of Narcotics (CBN) successfully executed “Operation Vajra,” seizing a massive export consignment of 120 million (12 crore) high-strength Tramadol Hydrochloride tablets....
DCGI Approves Qdenga, Marking India’s First Dengue Vaccine
Takeda Biopharmaceuticals India has received market authorisation from the Drug Controller General of India (DCGI) for Qdenga, making it the country's first licensed dengue vaccine....
